Posts tagged Controlled Substances Act
First Federal Lawsuit Spawns from FDA Approval of Cannabis-Based CBD

In the wake of the June 25th decision by the Federal Drug Administration to approve a cannabis-based CBD-rich epilepsy medication from GW Pharma, a new lawsuit has been filed by a medical marijuana user against the federal government.

The plaintiff is essentially calling the FDA as her first witness and this has the federal government tiptoeing through a minefield of their own making.

Read More
CBD Treatment Approved by FDA Could Carry Cannabis to Rescheduling

The FDA’s Center for Drug Evaluation and Research has approved the legal use of CBD for patients ages 2 and up who suffer from very specific conditions: Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS), two severe forms of childhood-onset epilepsy. With so much public support in the US for cannabis legalization – not just CBD legalization – the time is right for a major overhaul.

Read More